UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study

Neurology, 2012-04, Vol.78 (15), p.1171-1178

2012

Volltextzugriff (PDF)

Broadening the spectrum of controls for skin biopsy in painful neuropathies

Muscle & nerve, 2010-09, Vol.42 (3), p.435-437

2010

Volltextzugriff (PDF)

Urate as a predictor of the rate of clinical decline in Parkinson disease

Archives of neurology (Chicago), 2009-12, Vol.66 (12), p.1460

2009

Volltextzugriff (PDF)

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

Annals of neurology, 2009-10, Vol.66 (4), p.460-471

2009

Volltextzugriff (PDF)

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

The Lancet (British edition), 2009-02, Vol.373 (9665), p.732-738

2009

Volltextzugriff (PDF)

Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis

Nature clinical practice. Neurology, 2009-02, Vol.5 (2), p.82-92

2009

Volltextzugriff (PDF)

Transtelephonic Home Blood Pressure to Assess the Monoamine Oxidase-B Inhibitor Rasagiline in Parkinson Disease

Hypertension (Dallas, Tex. 1979), 2008-09, Vol.52 (3), p.587-593

2008

Volltextzugriff (PDF)

Pain associated with multiple sclerosis: Systematic review and proposed classification

Pain (Amsterdam), 2008-06, Vol.137 (1), p.96-111

2008

Volltextzugriff (PDF)

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

Archives of neurology (Chicago), 2008-06, Vol.65 (6), p.716

2008

Volltextzugriff (PDF)

Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome

Multiple sclerosis, 2008-04, Vol.14 (3), p.425-427

2008

Volltextzugriff (PDF)

PATIENT MANAGEMENT PROBLEM

Continuum (Minneapolis, Minn.), 2007-10, Vol.13, p.219-225

Schwid, Steven R.

2007

Volltextzugriff (PDF)

SYMPTOMATIC MANAGEMENT OF MULTIPLE SCLEROSIS

Continuum (Minneapolis, Minn.), 2007-10, Vol.13, p.181-197

Schwid, Steven R.

2007

Volltextzugriff (PDF)

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis

Clinical therapeutics, 2007-09, Vol.29 (9), p.2031-2048

2007

Volltextzugriff (PDF)

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis

Clinical therapeutics, 2007-09, Vol.29 (9), p.2031-2048

2007

Volltextzugriff (PDF)

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon [beta]-1a for relapsing multiple sclerosis

Clinical therapeutics, 2007-09, Vol.29 (9), p.2031

2007

Volltextzugriff (PDF)

Cognitive function in relapsing multiple sclerosis: Minimal changes in a 10-year clinical trial

Journal of the neurological sciences, 2007-04, Vol.255 (1), p.57-63

2007

Volltextzugriff (PDF)

Comparison of mobility device delivery within Department of Veterans Affairs for individuals with multiple sclerosis versus spinal cord injury

Journal of rehabilitation research and development, 2007-01, Vol.44 (5), p.693-701

2007

Volltextzugriff (PDF)

Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline

Movement disorders, 2006-10, Vol.21 (10), p.1716-1721

2006

Volltextzugriff (PDF)

Futility studies: spending a little to save a lot

Neurology, 2006-03, Vol.66 (5), p.626-627

2006

Volltextzugriff (PDF)

Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a

Neurology, 2005-12, Vol.65 (12), p.1964-1966

2005

Volltextzugriff (PDF)

Message from the Editors to our U.S. and International Reviewers

Neurology, 2005-12, Vol.65 (12), p.1850-1854

2005

Volltextzugriff (PDF)

Message from the Editors to our U.S. and International Reviewers

Neurology, 2005-06, Vol.64 (12), p.1996-2000

2005

Volltextzugriff (PDF)

Bias, not conflict of interest, is the enemy

Neurology, 2005-06, Vol.64 (11), p.1830-1831

2005

Volltextzugriff (PDF)

Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study

Archives of neurology (Chicago), 2005-05, Vol.62 (5), p.785

2005

Volltextzugriff (PDF)

Lower phenytoin serum levels in persons switched from brand to generic phenytoin

Neurology, 2005-04, Vol.64 (8), p.1485-1486

Wiberg, Cody C

2005

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

ThemaDisability Evaluation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(56)
Buchkapitel
(1)

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study

Broadening the spectrum of controls for skin biopsy in painful neuropathies

Urate as a predictor of the rate of clinical decline in Parkinson disease

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis

Transtelephonic Home Blood Pressure to Assess the Monoamine Oxidase-B Inhibitor Rasagiline in Parkinson Disease

Pain associated with multiple sclerosis: Systematic review and proposed classification

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome

PATIENT MANAGEMENT PROBLEM

SYMPTOMATIC MANAGEMENT OF MULTIPLE SCLEROSIS

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon [beta]-1a for relapsing multiple sclerosis

Cognitive function in relapsing multiple sclerosis: Minimal changes in a 10-year clinical trial

Comparison of mobility device delivery within Department of Veterans Affairs for individuals with multiple sclerosis versus spinal cord injury

Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline

Futility studies: spending a little to save a lot

Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a

Message from the Editors to our U.S. and International Reviewers

Message from the Editors to our U.S. and International Reviewers

Bias, not conflict of interest, is the enemy

Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study

Lower phenytoin serum levels in persons switched from brand to generic phenytoin

Aktive Filter

Suchergebnisse filtern